These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38651006)

  • 41. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
    Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
    Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    El-Mezayen HA; Habib S; Marzok HF; Saad MH
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of triggering receptor expressed on myeloid cells-2 prognostic evaluation in hepatitis B virus-related acute-on-chronic liver failure].
    Chen SL; Li XP; Gao L; Che YM; Zhang LL; Cheng XY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1306-1312. PubMed ID: 38253075
    [No Abstract]   [Full Text] [Related]  

  • 45. The relationship and diagnostic efficacy of N-terminal propeptide type III collagen in pathological changes associated with non-alcoholic steatohepatitis.
    Mi YJ; Zhang Z; Jin SL; Yan HM; Yang XM; Zhao J; Liu RX; Wu Y
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1052-1059. PubMed ID: 38375710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases.
    Ali AL; Nailwal NP; Doshi GM
    Endocr Metab Immune Disord Drug Targets; 2022; 22(4):371-382. PubMed ID: 34819013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
    Boeker KH; Haberkorn CI; Michels D; Flemming P; Manns MP; Lichtinghagen R
    Clin Chim Acta; 2002 Feb; 316(1-2):71-81. PubMed ID: 11750276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
    Harrison SA; Ruane PJ; Freilich B; Neff G; Patil R; Behling C; Hu C; Shringarpure R; de Temple B; Fong E; Tillman EJ; Rolph T; Cheng A; Yale K
    JHEP Rep; 2023 Jan; 5(1):100563. PubMed ID: 36644237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
    Dong H; Xu C; Zhou W; Liao Y; Cao J; Li Z; Hu B
    Clin Chim Acta; 2018 Aug; 483():145-150. PubMed ID: 29709450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
    Koivisto H; Hietala J; Niemelä O
    Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic significance of serum type IV collagen (IVC) combined with aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio in liver fibrosis.
    Niu A; Qi T
    Ann Transl Med; 2022 Dec; 10(24):1310. PubMed ID: 36660657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basement membrane peptides as markers of liver disease in chronic hepatitis C.
    Walsh KM; Fletcher A; MacSween RN; Morris AJ
    J Hepatol; 2000 Feb; 32(2):325-30. PubMed ID: 10707874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection.
    Elbaz S; Mousa N; Elmetwalli A; Abdel-Razik A; Salah M; ElHammady A; Abdelsalam M; Abdelkader E; El-Wakeel N; Eldars W; El-Emam O; Elbeltagy A; Shaheen M; El-Zamek H; Mousa E; Deiab A; Elgamal A; Habib A
    BMC Infect Dis; 2024 Jan; 24(1):134. PubMed ID: 38273234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation.
    Chen J; Liu C; Chen H; Liu Q; Yang B; Ou Q
    J Clin Lab Anal; 2013 Jan; 27(1):5-11. PubMed ID: 23292737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway.
    Li X; Zhang W; Xu K; Lu J
    Pathol Res Pract; 2020 May; 216(5):152876. PubMed ID: 32089410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-34 is more suitable than macrophage colony-stimulating factor for predicting liver significant fibrosis in patients with chronic hepatitis B.
    Yang K; Ying P; Sun B
    Scand J Gastroenterol; 2024; 59(1):78-84. PubMed ID: 37698305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.
    Hernández-Bartolomé Á; López-Rodríguez R; Borque MJ; González-Moreno L; Real-Martínez Y; García-Buey L; Moreno-Otero R; Sanz-Cameno P
    World J Gastroenterol; 2016 Nov; 22(44):9744-9751. PubMed ID: 27956798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.